SEC Form 4 · accession 0001493152-26-040116
EXOZYMES INC. · EXOZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tyler Paz Korman
Officer — Chief Scientific Officer
Period of report
Aug 19, 2026
Accepted (ET)
Aug 25, 2026 · 6:57 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002010788
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 19, 2026 | M | 32,964 | — | A | 762,837 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Aug 19, 2026 | M | 32,964 | D | — | — | Common Stock | 32,964 | 46,140 | D |
Explanation of responses
- F1The RSU convert on a one-for-one basis.
- F2On March 28, 2022, and May 1, 2023, the reporting person was granted an aggregate of 79,104 RSUs, vesting periodically. The first vesting was August 19, 2026, in the amount of 32,964 shares of common stock.